Equator Therapeutics logo

Equator Therapeutics Funding & Investors

Equator Therapeutics develops a drug that burns calories and improves metabolism. It offers a drug that can solve obesity and type 2 diabetes problem because it addresses the root cause of metabolic disorders. Its drug will target mitochondria, the powerhouse of the cell. It will activate the protein that mitochondria naturally use to produce heat. The company's approach has been proven to reverse obesity and type 2 diabetes in animals. It has developed a high-throughput drug discovery platform to identify compounds that selectively activate its target protein, without side effects.

equatortherapeutics.com

Total Amount Raised: $650,000

Equator Therapeutics Funding Rounds

  • Series Unknown

    $500,000

    Series Unknown Investors

    Alameda Research
  • Seed

    $150,000

    Seed Investors

    Y Combinator
Funding info provided by Diffbot.